Following the success of last year's event, Radcliffe Cardiology is proud to present the second edition of our one-day event, Advancements in Obesity Management (AOM).
Taking place on Wednesday 11 June 2025, this event delves into the intricate connections between obesity and cardio-renal-metabolic (CVRM) diseases, highlighting the shared pathways that contribute to these conditions.
Join us for this live event to enhance your understanding of evidence-based, personalised treatment strategies to reduce the impact of obesity. Led by Course Directors Dr Harold Bays (Louisville Metabolic and Atherosclerosis Research Centre, US) and Prof Naveed Sattar (University of Glasgow, UK), the programme brings together a panel of distinguished global experts in the field of obesity and cardiovascular disease.
Register today to stay at the forefront of advancements in practical obesity therapy. We look forward to welcoming you back to this insightful event.
*Advancements in Obesity Management’s programme will be submitted to the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) seeking 4 CME credits, equating to 4 hours of effective education time. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.
(Please note this programme is subject to change)
Plenary Session
Session 1: Obesity-Related Health Risks: The Scale of the Problem
- Defining a patient's risk of living with obesity (case example)
- How obesity impacts multiple comorbidities (CVD, T2DM, Hypertension, Thrombosis, Sleep Apnea, Osteoarthritis, Chronic Renal Insufficiency and beyond)
- Understanding underlying pathologies and diagnosis of fatty liver disease
- Discussion – Risk Assessment in practice
Plenary Session
Session 2: Choices of Intervention and Essential Outcomes Data
- Health impact of nutritional, physical activity and behaviour modifications
- Safety and efficacy of bariatric procedural approaches
- Latest data on pharmacological therapy on important health outcomes
Plenary Session
Session 3: Essentials of Patient Management: Real-World Implementation
- Guidelines, referrals and defining treatment goals
- Role of bariatric procedures
- Role of anti-obesity medication, initiation and management
- The MDT approach to patient management: personalising care
Plenary Session
Session 4: The Way Forward
- Patient case review: therapy now and potential future (return to earlier case)
- Rational and mechanism of developing pharmacological novel anti-obesity therapies
- Emerging clinical data and ongoing outcomes trials with anti-obesity medication
- Summary and close
Harold Bays
Course Director
Louisville Metabolic and Atherosclerosis Research Center, Louisville, US
more info
Naveed Sattar
Course Director
University of Glasgow, Glasgow, UK
more info
- Participants will be able to discuss their role in referral pathways and practical patient management
- Apply current treatment methodologies to reduce the impact of obesity on cardio-renal-metabolic diseases and non-metabolic obesity related diseases utilising the multidisciplinary team
- Interpret and discuss clinical trial data for emerging obesity therapies and their wider metabolic impact beyond weight loss
- Apply evidence-based treatment methodologies to reduce the impact of obesity through the multidisciplinary team (MDT) and a personalised care approach
- Cardiologists
- Diabetologists
- Endocrinologists
- Neurologists
- Nurses
- Obesity Specialists
- Primary Care Physicians
If you’re interested in becoming an educational partner at AOM, please contact sales@radcliffe-group.com
Official Journal
European Cardiology Review (ECR) is an international, English-language, peer-reviewed journal that publishes articles continuously on ECRjournal.com. It aims to assist time-pressured physicians to stay abreast of key advances and opinions in the area of cardiovascular disease.
The journal comprises balanced and comprehensive review articles written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.
The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.
About Radcliffe CVRM
We are Radcliffe, a knowledge network for the cardiovascular community
Radcliffe CVRM is a trusted global platform dedicated to advancing the understanding and treatment of cardiovascular and metabolic risk. Through expert insights, research dissemination, and educational initiatives, we’re here to provide healthcare professionals with the tools and knowledge needed to improve patient outcomes in these critical fields.
We bring medical knowledge to life
From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.
Our work is underpinned by 3 core principles:
- We build on the best science
- We work hands-on with our community
- We bring fresh thinking
Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.
For more information on Radcliffe CVRM, please visit www.radcliffecvrm.com